Misalignment between U.S. disease burden and novel therapy innovation may contribute to an increase in U.S. disease prevalence, morbidity, and premature mortality, and may exacerbate existing health ...
Jason Porter, MD, outlines the most significant unaddressed challenges in treating and managing non-small cell lung cancer as the field approaches the American Society of Clinical Oncology's 2024 ...
Oncology is a critical area of healthcare, posing significant challenges yet offering substantial opportunities for innovation, particularly in pharma drug development. The seriousness of cancer is ...
The Mark Foundation Endeavor Awards support collaborative research projects that bring together investigators with diverse areas of expertise to tackle challenges in the prevention, diagnosis, and ...
Experts discuss the challenges of integrating new cancer therapies, addressing multidisciplinary care, evolving guidelines, and the financial burden on patients. As HER2-targeted therapies continue to ...
Findings highlight opportunity for shared decision-making to improve treatment planning, with more than 90% of patients currently on injectables willing to switch to a new oral therapy with equivalent ...
Science X is a network of high quality websites with most complete and comprehensive daily coverage of the full sweep of ...
For businesses aiming to thrive in today’s fast-paced world, innovation isn’t a buzzword—it’s a strategic and operational ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results